AQSN - Dohgu,S.; Yamauchi,A.; Takata,F.; Sawada,Y.; Higuchi,S.; Naito,M.; Tsuruo,T.; Shirabe,S.; Niwa,M.; Katamine,S.; Kataoka,Y. - Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier - Cellular and Molecular Neurobiology 2004 Apr; 24(2): 205-17
APVF - Nakajima,M.; Yamada,T.; Kusuhara,T.; Furukawa,H.; Takahashi,M.; Yamauchi,A.; Kataoka,Y. - Results of quinacrine administration to patients with Creutzfeldt-Jakob disease - Dementia and Geriatric Cognitive Disorders 2004; 17(3): 158-163
ARSZ - Satoh,K.; Shirabe,S.; Eguchi,K.; Yamauchi,A.; Kataoka,Y.; Niwa,M.; Nishida,N.; Katamine,S. - Toxicity of quinacrine can be reduced by co-administration of P-glycoprotein inhibitor in sporadic Creutzfeldt-Jakob disease - Cellular and Molecular Neurobiology 2004 Dec; 24(6): 873-5
ANGU - Yamauchi,K. - [Issues association with SBE] - Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese Journal of Toxicology 2002 Jul; 15(3): 271-9
AMUT - Yamauchi,K. - [Several problems concerning bovine spongiform encephalopathy] - Journal of Toxicological Sciences 1996 Aug; 21(3 Appendix): 143-50